John R. Penrod
John R. Penrod publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Cancer Immunotherapy and Biomarkers.
- World rank
- #526,613 of 7,710,434 ranked researchers
- Rank in United States
- #182,710 of 1,627,098
- Works
- 121
- Citations
- 3.9k
- Citations per work
- 32.4
What does John R. Penrod research?
John R. Penrod's work is mostly in Medicine (61%), Economics, Econometrics and Finance (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7461.2%
- Medicine7461.2%
- Everything else3025.2%
- Social Sciences1613.6%
- 1Pulmonary and Respiratory Medicine32% of their works
- 2Oncology20% of their works
- 3Economics and Econometrics14% of their works
- 4Rheumatology4% of their works
- 5Surgery4% of their works
- 6Epidemiology2% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Research Studies
- Economic and Financial Impacts of Cancer
- Rheumatoid Arthritis Research and Therapies
- Dental Implant Techniques and Outcomes
Which keywords describe John R. Penrod's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, CT Screening, Lung Cancer and Immune Checkpoint Blockade.
- Dental Implants
- Inflammation
- Genomic Profiles
- Cost of Care
- Cost-effectiveness Analysis
- Immune Checkpoint Blockade
- CT Screening
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Lung Cancer
- PD-1 and PD-L1
- Quality of Life
- Financial Toxicity
- Small-Cell Lung Cancer
- Rheumatoid Arthritis
- Peri-implant Diseases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Clinical Trials662 topics
- Targeted Therapy662 topics
- Chemotherapy582 topics
- ALK Inhibitors511 topic
- EGFR Mutations511 topic
- CT Screening431 topic
- Lung Cancer431 topic
- Immune Checkpoint Blockade411 topic
- PD-1 and PD-L1411 topic
- Cost-effectiveness Analysis191 topic
- Quality of Life191 topic
- Cost of Care151 topic
- Financial Toxicity151 topic
- Genomic Profiles151 topic
- Small-Cell Lung Cancer151 topic
- Inflammation71 topic
- Rheumatoid Arthritis71 topic
- Dental Implants51 topic
- Peri-implant Diseases51 topic
Where does John R. Penrod work?
John R. Penrod's main affiliation in the publication record is Bristol-Myers Squibb (United States), United States.
How many publications and citations does John R. Penrod have?
OpenAlex counts 121 works and 3,918 citations for John R. Penrod, an h-index of 31, ranking #526,613 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John R. Penrod. Posts are plain text and can be reported.